Adherence to dietary and physical activity recommendations is often unmeasured, making it difficult to isolate medication effects from lifestyle factors
Judk P, Esposito S, Coppieters G, Van Eenoo P, Deventer K
"What makes it stand out is that it targets three hormone pathways simultaneously: GLP-1, GIP and glucagon, [which are] involved in hunger, fullness, blood sugar [regulation] and metabolism
Thats what people are trying to lose
Priority Review designation is possible given the magnitude of the trial results, which could shorten this timeline to 6 months
Days five through seven (the taper) As blood levels decline toward the end of the weekly cycle, some people notice a gradual return of appetite